NYSE ยท Healthcare ยท Drug Manufacturers - General
Market Cap
$1.14T
SectorHealthcare
IndustryDrug Manufacturers - General
52-Week Low$623.78
52-Week High$1215.57
CEODavid A. Ricks
IPO DateJun 1, 1972
Employees47,000
CountryUnited States
Eli Lilly and Company is a prominent global pharmaceutical firm dedicated to the research, development, and commercialization of human medicines across the world. Its therapeutic offerings include a comprehensive suite of diabetes medications. This encompasses various insulin formulations like Basaglar, the Humalog family (e.g., Mix 75/25, U-100, U-200, Mix 50/50), insulin lispro products (including protamine and mix 75/25), and the Humulin line (e.g., 70/30, N, R, U-500).